No Picture
News

Cidara Therapeutics to Present Data from its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference

SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that five abstracts, including one late-breaker, highlighting data from its Cloudb… […]

No Picture
News

Scientist.com Named to Inc. 500 List for Third Consecutive Year with Three-Year Revenue Growth of 1,522%

SAN DIEGO–(BUSINESS WIRE)–#fasterscience–Inc. magazine today revealed that Scientist.com, the world?s largest enterprise marketplace for outsourced R&D services, ranked no. 289 on its Inc. 5000 list, the prestigious ranking of the nation?s faste… […]

No Picture
News

A budget biotech you likely never heard about is setting a course for Wall Street with some modest ambitions

A low-profile biotech founded by an exec with some deep roots in California biotech has mapped out plans for a very modest-sounding IPO.
Monopar Therapeutics is making a $40 million IPO play out of San Diego, where it?s been working on a handful of dru… […]

No Picture
News

UPDATED: Watch out Bayer, Roche is coming for you with a rival to the tumor agnostic drug you got from Loxo

Just ahead of schedule the FDA has come through with a key approval for Genentech?s entrectinib ? now headed to the market as Rozlytrek.
Regulators approved the drug for ROS1-positive, metastatic non-small cell lung cancer as well as adult and pediatri… […]